Comments
Loading...
TG Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:TGTX | Benzinga
TG Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 30
EPS Estimate
$0.140
Quarterly Revenue Estimate
$113.92M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$329.00M
Analyze the earnings history of TG Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG Therapeutics | -$0.07 | $0.14 | — | — | $63.47M | $113.92M | — | — | 04/30/2025 | Get Alert |
| TGTX | TG Therapeutics | -$0.10 | $0.08 | $0.15 | 87.50% | $43.97M | $98.54M | $108.19M | 9.79% | 03/03/2025 | Get Alert |
| TGTX | TG Therapeutics | $0.73 | $0.03 | $0.02 | -33.33% | $165.81M | $81.71M | $83.88M | 2.65% | 11/04/2024 | Get Alert |
| TGTX | TG Therapeutics | -$0.34 | -$0.05 | $0.04 | 180.00% | $16.07M | $65.89M | $73.47M | 11.50% | 08/06/2024 | Get Alert |
| TGTX | TG Therapeutics | -$0.28 | -$0.04 | -$0.07 | -75.00% | $7.80M | $54.58M | $63.47M | 16.30% | 05/01/2024 | Get Alert |
| TGTX | TG Therapeutics | -$0.39 | -$0.10 | -$0.09 | 10.00% | $80.00K | $40.06M | $43.97M | 9.76% | 02/28/2024 | Get Alert |
| TGTX | TG Therapeutics | -$0.26 | $0.12 | $0.73 | 508.33% | $94.00K | $46.56M | $165.81M | 256.13% | 11/01/2023 | Get Alert |
| TGTX | TG Therapeutics | -$0.30 | -$0.25 | -$0.34 | -36.00% | $594.00K | $17.45M | $16.07M | -7.89% | 08/01/2023 | Get Alert |
| TGTX | TG Therapeutics | -$0.51 | -$0.37 | -$0.28 | 24.32% | $2.02M | $3.38M | $7.80M | 130.86% | 05/01/2023 | Get Alert |
| TGTX | TG Therapeutics | -$0.70 | -$0.26 | -$0.39 | -50.00% | $2.32M | — | $80.00K | — | 02/28/2023 | Get Alert |
| TGTX | TG Therapeutics | -$0.65 | -$0.34 | -$0.26 | 23.53% | $2.03M | — | $94.00K | — | 11/10/2022 | Get Alert |
| TGTX | TG Therapeutics | -$0.59 | -$0.51 | -$0.30 | 41.18% | $1.54M | $200.00K | $594.00K | 197.00% | 08/08/2022 | Get Alert |
| TGTX | TG Therapeutics | -$0.69 | — | -$0.51 | — | $793.00K | — | $2.02M | — | 05/10/2022 | Get Alert |
| TGTX | TG Therapeutics | -$0.71 | -$0.63 | -$0.70 | -11.11% | $38.00K | $6.74M | $2.32M | -65.56% | 03/01/2022 | Get Alert |
| TGTX | TG Therapeutics | -$0.73 | -$0.56 | -$0.65 | -16.07% | $38.00K | $2.97M | $2.03M | -31.65% | 11/04/2021 | Get Alert |
| TGTX | TG Therapeutics | -$0.47 | -$0.50 | -$0.59 | -18.00% | $38.00K | — | $1.54M | — | 08/02/2021 | Get Alert |
| TGTX | TG Therapeutics | -$0.48 | -$0.49 | -$0.69 | -40.82% | $38.00K | $650.00K | $793.00K | 22.00% | 05/10/2021 | Get Alert |
| TGTX | TG Therapeutics | -$0.44 | -$0.58 | -$0.71 | -22.41% | $38.00K | $38.00K | $38.00K | 0.00% | 03/02/2021 | Get Alert |
| TGTX | TG Therapeutics | -$0.69 | — | -$0.73 | — | $38.00K | — | $38.00K | — | 11/09/2020 | Get Alert |
| TGTX | TG Therapeutics | -$0.42 | -$0.34 | -$0.47 | -38.24% | $38.00K | — | $38.00K | — | 08/10/2020 | Get Alert |
| TGTX | TG Therapeutics | -$0.43 | — | -$0.48 | — | $38.00K | — | $38.00K | — | 05/11/2020 | Get Alert |
TG Therapeutics (TGTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $0.15 | $0.08 | 87.5 % |
| Q3 | 2024-11-04 | $0.02 | $0.03 | -33.3 % |
| Q2 | 2024-08-06 | $0.04 | $-0.05 | 180.0 % |
| Q1 | 2024-05-01 | $-0.07 | $-0.04 | -75.0 % |
TG Therapeutics (TGTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $108.19M | $98.54M | 9.79 % |
| Q3 | 2024-11-04 | $83.88M | $81.71M | 2.65 % |
| Q2 | 2024-08-06 | $73.47M | $65.89M | 11.5 % |
| Q1 | 2024-05-01 | $63.47M | $54.58M | 16.3 % |
FAQ
When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?
TG Therapeutics (TGTX) is scheduled to report earnings on April 30, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for TG Therapeutics (NASDAQ:TGTX)?
The Actual EPS was $0.15, which beat the estimate of $0.08.
What were TG Therapeutics’s (NASDAQ:TGTX) revenues?
The Actual Revenue was $108.2M, which beat the estimate of $98.5M.
Browse earnings estimates, EPS, and revenue on all stocks.